These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 36585721

  • 1. Predicting immunoglobulin resistance in Kawasaki disease: an assessment of neutrophil to lymphocyte platelet ratio.
    Lu Y, Tang Y, Wang B, Li X, Xu Q, Chu H, Lv H, Lu M, Qin Y.
    Ital J Pediatr; 2022 Dec 30; 48(1):208. PubMed ID: 36585721
    [Abstract] [Full Text] [Related]

  • 2. The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study.
    Kanai T, Takeshita S, Kawamura Y, Kinoshita K, Nakatani K, Iwashima S, Takizawa Y, Hirono K, Mori K, Yoshida Y, Nonoyama S.
    Heart Vessels; 2020 Oct 30; 35(10):1463-1472. PubMed ID: 32449049
    [Abstract] [Full Text] [Related]

  • 3. A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
    Takeshita S, Kanai T, Kawamura Y, Yoshida Y, Nonoyama S.
    PLoS One; 2017 Oct 30; 12(5):e0176957. PubMed ID: 28542183
    [Abstract] [Full Text] [Related]

  • 4. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
    Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
    World J Pediatr; 2020 Dec 30; 16(6):607-613. PubMed ID: 32232677
    [Abstract] [Full Text] [Related]

  • 5. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
    Ha KS, Lee J, Lee KC.
    Eur J Pediatr; 2020 Feb 30; 179(2):257-264. PubMed ID: 31713683
    [Abstract] [Full Text] [Related]

  • 6. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Feb 30; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 7. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 30; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
    Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
    Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
    [Abstract] [Full Text] [Related]

  • 9. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N, Silvilairat S, Makonkawkeyoon K, Pongprot Y, Sittiwangkul R.
    Paediatr Int Child Health; 2018 Aug 25; 38(3):209-212. PubMed ID: 29768976
    [Abstract] [Full Text] [Related]

  • 10. The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.
    Kawamura Y, Takeshita S, Kanai T, Yoshida Y, Nonoyama S.
    J Pediatr; 2016 Nov 25; 178():281-284.e1. PubMed ID: 27526622
    [Abstract] [Full Text] [Related]

  • 11. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 12. [Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease].
    Yuan YD, Sun J, Li PF, Wei CL, Yu YH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr 21; 19(4):410-413. PubMed ID: 28407827
    [Abstract] [Full Text] [Related]

  • 13. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
    Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B.
    Int Immunopharmacol; 2020 Dec 21; 89(Pt A):107037. PubMed ID: 33242833
    [Abstract] [Full Text] [Related]

  • 14. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
    Huang H, Jiang J, Shi X, Qin J, Dong J, Xu L, Huang C, Liu Y, Zheng Y, Hou M, Shen Q, Zeng B, Qian G, Yang F, Lv H.
    Ann Med; 2022 Dec 21; 54(1):442-453. PubMed ID: 35099338
    [Abstract] [Full Text] [Related]

  • 15. Value of neutrophil-lymphocyte ratio in predicting outcomes in Kawasaki disease.
    Ha KS, Lee J, Jang GY, Lee J, Lee KC, Son CS, Lee JW.
    Am J Cardiol; 2015 Jul 15; 116(2):301-6. PubMed ID: 25975725
    [Abstract] [Full Text] [Related]

  • 16. Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness.
    Wang Y, Li Z, Hu G, Hao S, Deng X, Huang M, Ren M, Jiang X, Kanegaye JT, Ha KS, Lee J, Li X, Jiang X, Yu Y, Tremoulet AH, Burns JC, Whitin JC, Shin AY, Sylvester KG, McElhinney DB, Cohen HJ, Ling XB, Pediatric Emergency Medicine Kawasaki Disease Research Group.
    PLoS One; 2016 Jul 15; 11(12):e0167434. PubMed ID: 28002448
    [Abstract] [Full Text] [Related]

  • 17. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
    Cardiovasc Ther; 2021 Jul 15; 2021():6660407. PubMed ID: 34239607
    [Abstract] [Full Text] [Related]

  • 18. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 15; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 19. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 15; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 20. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
    Turk J Pediatr; 2020 Nov 15; 62(1):1-9. PubMed ID: 32253860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.